# Trending Content OS — Daily Run
**Run date:** 2026-09-18

---

## 1. Preflight Summary

```yaml
preflight_status:
  all_sections_present: true
  missing_sections: []
  site_niche_set: true
  target_audience_set: true
  site_url_set: false
  serpapi_connected: true
  google_trends_available: true
  google_trends_tool: "serpapi_prefetch"
  active_tools: [serpapi_google_trends, serpapi_google_news, rss_config, trusted_sources, competitor_list]
  inactive_tools: [content_database, arxiv_search, youtube_api, google_sheets]
  can_run_signal_listener: true
  notes: >
    site_url not configured — self-check skipped; competitor-list fallback (configs/competitor_list.yaml)
    used for duplicate/SERP-gap context. No data/deferred_topics.yaml entries with a passed recheck_on
    date were found. Run-history recurrence check: FDA/consumer recalls, mental-health-at-work signals,
    and "AI entering clinical medicine" have each appeared in 2+ consecutive runs (9/12–9/17) — flagged
    as recurring/monitor-for-staleness rather than re-briefed today.
```

---

## 2. Google News Radar Coverage Summary

144 unique headlines reviewed across 12 queries. Clustered into 6 groups:

| Cluster | Example headlines | Disposition |
|---|---|---|
| **Health policy/business/hospital admin** | [Energy & Commerce Medicare hearing](https://energycommerce.house.gov/events/health-hearing-examining-legislative-proposals-to-reform-medicare-provider-payment-and-bolster-health-care-cybersecurity), [Allina doctors strike over AI diagnoses](https://www.mprnews.org/story/2026/09/16/allina-healths-doctors-strike-takes-on-ai-diagnoses), [NYC Health+Hospitals/Maimonides merger](https://www.nychealthandhospitals.org/pressrelease/nyc-health-hospitals-and-maimonides-health-transaction-moves-forward-after-new-york-state-health-planning-council-vote/), [Vermont healthcare layoffs](https://vtdigger.org/2026/09/15/hundreds-of-layoffs-announced-at-the-two-largest-healthcare-networks/) | **Rejected** — excluded categories (pure business/local hospital news/political healthcare policy) |
| **Local/PR wellness programs** | [NYT "Wellness Darties"](https://www.nytimes.com/2026/09/11/style/wellness-darties-college-gen-z-tiktok.html), [Disney gorilla wellness checkup](https://people.com/workers-hold-gorillas-hand-during-disney-wellness-checkup-12126619), university wellness-program PR (Purdue, Liberty, UMW, Case Western, UK) | **Rejected** — Wellness Darties is duplicate of 9/11 coverage; remainder is local PR/off-audience/off-topic (zoo-animal checkup) |
| **Medical study/research** | [Alzheimer's study funding cuts](https://www.theguardian.com/us-news/2026/sep/17/trump-cuts-alzheimers-disease-study) (Guardian), [UT Southwestern brain tumor metabolite](https://www.utsouthwestern.edu/newsroom/articles/year-2026/sept-aggressive-brain-tumor-growth.html), [anti-seizure drug vs childhood brain tumors](https://medicalxpress.com/news/2026-09-anti-seizure-drug-aggressive-childhood.html), Mayo minibeam (dup), intermittent fasting/Huntington's (dup) | **Mixed** — 2 retained (Alzheimer's funding, UTSW metabolite), 1 routed to 02b Monitor (anti-seizure drug), 2 rejected as duplicate (Mayo, Huntington's) |
| **Clinical trials** | [WaPo: FDA-ordered post-market studies not done](https://www.washingtonpost.com/health/2026/09/17/fda-ordered-studies-many-drugs-devices-market-are-not-done/), [HIV injections beat tablets for young people](https://medicalxpress.com/news/2026-09-hiv-tablets-young-people-clinical.html), FDA phase-1 pilot (dup of 9/16), Kaiser/Advocate/FIU trial-ops PR | **Mixed** — WaPo retained (P2); HIV injectable routed to 02b Monitor; remainder off-audience trial-ops trade press, rejected weak_signal |
| **FDA recalls** | [Hand soap Class II escalation](https://www.usatoday.com/story/money/consumer-protection/recalls-alerts/2026/09/16/hand-soap-recall-bacteria-states/91789354007/) (multi-outlet), [Walmart berries expanded](https://www.thehealthy.com/news/fda-walmart-berries-recall-update-september-2026/), [So Delicious ice cream recall — foreign material](https://nypost.com/2026/09/17/lifestyle/so-delicious-ice-cream-recalled-nationwide-over-stones-found-in-pints-fda/), [lead-leaching cookware warning](https://www.eatingwell.com/fda-lead-leaching-cookware-replacements-amazon-12114030) | **Mixed** — hand soap/berries = existing/duplicate (already covered, no material new angle); So Delicious + cookware routed to 02b and **rejected** (unverifiable, single secondary source, no primary FDA notice retrieved) |
| **Celebrity/trending-now** | [Porsha Williams emergency hysterectomy](https://www.glamour.com) (Google Trends breakout) | **Rejected** — celebrity personal medical news, no evidence/research angle; excluded category |

---

## 3. Signal Summary

```yaml
signal_summary:
  run_started_at: "2026-09-18T00:00:00Z"
  run_completed_at: "2026-09-18T00:20:00Z"
  total_signals_reviewed: 153
  total_signals_retained: 3
  total_rejected: 148
  google_trends_available: true
  search_velocity_source: "google_trends"
  rejection_breakdown:
    off_category: 70
    brand_safety: 0
    duplicate: 20
    weak_signal: 50
    unverified_claim: 2
    other: 6
  highest_priority_topic: "FDA-ordered post-market drug/device studies not completed (Washington Post)"
  strongest_signal_source: "Washington Post Health (tier-1)"
  tools_unavailable: [content_database]
  notes: >
    Google Trends "Trending Now" surfaced one breakout (Porsha Williams) — rejected as celebrity/off-category.
    No trend candidate cleared thresholds purely on search_velocity this run; the 3 retained candidates
    clear on source_credibility + opportunity_score (thin SERP coverage), consistent with a slower health
    news cycle. Recurring themes flagged per run-history check: FDA/consumer recalls (4th consecutive
    appearance), mental-health-at-work signals, "AI in clinical medicine" — all judged stale for new
    briefs today absent a materially new development.
```

---

## 4. Skill 02b — Health Claim Verification Gate: Routing Summary

| Topic | Risk type | Gate result | Reason |
|---|---|---|---|
| UT Southwestern — brain tumor metabolite study | medical_study | **Pass** (confidence capped medium) | Institutional press release from the study's own institution; journal publication assumed named per standard practice, not independently confirmed |
| HIV injections vs. tablets, young people | clinical_trial / drug_or_treatment_claim | **Monitor** | Medical Xpress headline doesn't name the trial/DOI; Medical Xpress is not a trusted-tier outlet capable of substituting for primary evidence. Requires editorial verification before scoring. |
| Anti-seizure drug vs. childhood brain tumors | drug_or_treatment_claim | **Monitor** | Same issue — single non-trusted-tier secondary source, no traceable primary identifier |
| "So Delicious" ice cream recall (foreign material) | recall | **Reject** — unverifiable_health_claim | Single secondary source (NY Post); breaking-recall exception requires 3+ credible corroborating sources or a directly retrieved FDA notice — neither present |
| FDA lead-leaching cookware warning | dosage_or_safety_guidance | **Reject** — unverifiable_health_claim | Single secondary source (EatingWell); dosage/safety guidance requires primary source, no substitution permitted; no FDA.gov notice retrieved |

Both Monitor topics exit to P5 for editorial review and do **not** receive trend/opportunity/discover scores per protocol.

---

## 5. Final Editorial Priority Board

| Priority | Topic | Publish Timing | Trend | Opp. | Discover | Urgency | Confidence | Key Source |
|---|---|---|---|---|---|---|---|---|
| **P2** | FDA-ordered post-market studies not completed | short_term | 54 | 78 | 4 | this_week | low | [WaPo](https://www.washingtonpost.com/health/2026/09/17/fda-ordered-studies-many-drugs-devices-market-are-not-done/) |
| **P2** | Alzheimer's research funding cuts delay patient results | short_term | 52 | 68 | 3 | today | low | [The Guardian](https://www.theguardian.com/us-news/2026/sep/17/trump-cuts-alzheimers-disease-study) |
| **P3** | New metabolite discovered fueling aggressive brain tumor growth | scheduled | 50 | 62 | 3 | this_week | low | [UT Southwestern](https://www.utsouthwestern.edu/newsroom/articles/year-2026/sept-aggressive-brain-tumor-growth.html) |
| **P5** | HIV injections outperform tablets for young people | monitor | — | — | — | — | — | [Medical Xpress](https://medicalxpress.com/news/2026-09-hiv-tablets-young-people-clinical.html) |
| **P5** | Anti-seizure drug fights childhood brain tumors | monitor | — | — | — | — | — | [Medical Xpress](https://medicalxpress.com/news/2026-09-anti-seizure-drug-aggressive-childhood.html) |

```yaml
summary:
  total_topics: 5
  high_priority_count: 0
  immediate_actions: "None qualify for P1 today — no breaking, multi-source-corroborated story cleared thresholds. Top 2 P2 items should move into production this week; both are single-source and need a corroborating outlet check before publish."
```

---

## 6. Editorial Briefs — Retained Candidates

### P2 — FDA-ordered post-market studies not completed
```yaml
priority_level: P2
publish_timing: short_term
topic: "Washington Post investigation: many FDA-ordered post-market drug and device studies never completed"
primary_entity: "FDA post-market study requirements"
signal_type: policy_or_regulatory_change
allowed_category: "FDA and CDC regulatory updates"
trend_strength_score: 54
opportunity_score: 78
discover_score: 4
urgency: this_week
confidence: low
content_status: new
source_count: 1
recommended_angle: "Explainer: 'Why does the FDA let some drugs and devices stay on the market without finishing the safety studies it required?' — translate the WaPo investigation into a consumer-facing accountability piece with a checklist of how to look up a drug's post-market study status."
why_now: "WaPo's 9/17 investigation surfaces a structural FDA oversight gap with direct patient-safety relevance; no competitor has run a consumer-facing explainer version yet — clear SERP gap."
primary_headline: "The FDA Required These Safety Studies. Years Later, Many Still Aren't Done."
next_steps: "Corroborate via a second outlet or FDA's own openFDA post-market requirement database before publishing; identify 1–2 named drugs/devices from the WaPo piece to anchor the explainer."
notes: "⚠️ Integrity note: single-source (WaPo) story — confidence capped low until corroborated. High opportunity given thin consumer-facing SERP coverage of this specific angle."
sources:
  - { publisher: "Washington Post Health", url: "https://www.washingtonpost.com/health/2026/09/17/fda-ordered-studies-many-drugs-devices-market-are-not-done/", tier: 1, used_for: "Primary reporting" }
```

### P2 — Alzheimer's research funding cuts delay patient results
```yaml
priority_level: P2
publish_timing: short_term
topic: "Federal research funding cuts leave aging Alzheimer's study participants without results"
primary_entity: "Alzheimer's disease research funding"
signal_type: policy_or_regulatory_change
allowed_category: "aging and longevity"
trend_strength_score: 52
opportunity_score: 68
discover_score: 3
urgency: today
confidence: low
content_status: new
source_count: 1
recommended_angle: "Patient-impact framing (not partisan): what happens to a long-running Alzheimer's study — and its aging participants — when the funding that analyzes results disappears mid-study. Ground in research-continuity/patient-access terms, not political critique."
why_now: "Guardian's 9/17 report ties an active funding disruption to real patients awaiting individual study results — a concrete, ongoing harm distinct from generic policy debate."
primary_headline: "These Seniors Volunteered for an Alzheimer's Study. They May Never Learn the Results."
next_steps: "Seek a second, non-Guardian source or the study's own institutional statement to raise confidence before publishing; confirm study name/sponsor."
notes: "⚠️ Integrity note: single tier-2 source (Guardian); frame carefully to stay inside allowed categories (aging/longevity + patient access) and out of excluded 'pure political healthcare opinion.'"
sources:
  - { publisher: "The Guardian", url: "https://www.theguardian.com/us-news/2026/sep/17/trump-cuts-alzheimers-disease-study", tier: 2, used_for: "Primary reporting" }
```

### P3 — New metabolite fueling aggressive brain tumor growth
```yaml
priority_level: P3
publish_timing: scheduled
topic: "UT Southwestern identifies metabolite that fuels aggressive brain tumor growth"
angle: "Explain what the metabolite does in plain-language terms and what it could mean for future glioblastoma treatment — clearly framed as early-stage discovery science, not a near-term treatment."
key_data_points: ["Institutional press release from UT Southwestern (9/16/2026)", "Discovery-stage finding — no clinical application yet"]
integrity_flags: ["⚠️ Integrity note: single-institution press release; confirm named journal/DOI before publishing and clarify this is preclinical/discovery-stage, not a treatment breakthrough."]
expert_type_needed: "Neuro-oncologist or cancer metabolism researcher (academic/research_and_academia, per expert_sources.yaml) to contextualize significance"
seo:
  primary_keyword: "brain tumor metabolite discovery"
  format: "explainer"
  serp_difficulty: "Easy"
sources:
  - { publisher: "UT Southwestern Newsroom", url: "https://www.utsouthwestern.edu/newsroom/articles/year-2026/sept-aggressive-brain-tumor-growth.html" }
estimated_word_count: "600-800"
```

---

## 7. Rejected Topics Log (selected — full list = 148)

| Topic | Reason |
|---|---|
| Porsha Williams emergency hysterectomy | off_category — celebrity personal medical news, no evidence/research angle |
| Bakari the gorilla's wellness checkup | off_category — zoo-animal wellness, not human health |
| Wellness Darties (Gen Z alcohol-free gatherings) | duplicate — covered 9/11 |
| WHO "Mental health at work" | duplicate — covered 9/16 |
| Nature youth mental health diagnoses review | duplicate — covered 9/14 |
| Mayo Clinic minibeam radiotherapy | duplicate — covered 9/17 |
| Intermittent fasting / Huntington's | duplicate — covered 9/17 |
| FDA hand soap recall Class II escalation | duplicate — no material new angle since 9/16 coverage; severity reclassification only |
| Walmart Great Value blueberries — expanded states | duplicate — covered 9/14 |
| So Delicious ice cream recall | unverified_claim — see 02b routing (single source, no primary notice) |
| FDA lead-leaching cookware warning | unverified_claim — see 02b routing |
| Medicare provider payment/cybersecurity hearing | off_category — pure policy/legislative process |
| NYC Health+Hospitals/Maimonides merger | off_category — local hospital business news |
| Allina doctors' strike over AI diagnoses | off_category — labor dispute, not patient-facing health content |
| ~50 local/university wellness-program PR items | off_category / weak_signal — local, non-evidence-based |
| ~50 clinical-trial-ops trade press items (Kaiser, Advocate, FIU, ResearchPass, etc.) | weak_signal — industry-operations content, not audience-facing |

---

## 8. Integrity Flags — Consolidated

⚠️ WaPo post-market studies brief — single-source (WaPo); confidence capped low; corroborate before publish.
⚠️ Alzheimer's funding cuts brief — single-source (Guardian, tier-2); frame as patient-impact, not political opinion, to stay within category rules.
⚠️ UT Southwestern metabolite brief — single institutional press release; confirm DOI/journal; discovery-stage finding, not a treatment — do not overstate clinical relevance.
⚠️ Both P5 Monitor items (HIV injectable trial, anti-seizure drug study) are held specifically because their sole source (Medical Xpress) could not be verified against a primary trial/journal record — do not brief until resolved.

---

## 9. Run Notes

- No `data/deferred_topics.yaml` entries were due for recheck today.
- Recurring-theme flag (per run-history step): FDA/consumer recalls, mental-health-at-work signals, and "AI in clinical medicine" have each recurred 2+ consecutive runs with no materially new development today — held back from re-briefing to avoid redundant coverage; recommend checking for staleness if they recur again tomorrow.
- `site_url` not configured — duplicate/SERP-gap checks relied on the Recent Coverage list (last 7 days) plus `configs/competitor_list.yaml` fallback, not a live self-check.
- Thin P1 slate today is a genuine signal-quality finding, not a pipeline failure: nothing in the radar or Trends pre-fetch cleared both trend and opportunity thresholds with multi-source corroboration. Reported as such rather than padding the board.
- `data/run_history.yaml` should be updated with this run's entry (5 topics passed some stage: 3 scored, 2 monitor; 148 rejected; top topic = WaPo FDA post-market studies).